|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease显示文摘 | Vlad Ratziu Frédéric Charlotte Agnès Heurtier Sophie Gombert Philippe Giral Eric Bruckert André Grimaldi Frédérique Capron Thierry Poynard | 2005 | Gastroenterology2005，，7： | 4 |
| 2 | Elevated levels of interleukin- 6 are reduced in serum and subcutaneous adipose tissue of obese women after weig ht loss显示文摘 | Bastard JP Jardel C Bruckert E | 2000 | J Clin Endocrinol Metab2000，85，9： | 1 |
| 3 | Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin- intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial显示文摘 | MORIARTY PM JACOBSON TA BRUCKERT E | 2014 | J Clin Lipidol2014，8，6： | 1 |
| 4 | Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis显示文摘 | Eric Bruckert Julien Labreuche Dominique Deplanque Pierre-Jean Touboul Pierre Amarenco | 2011 | Journal of Cardiovascular Pharmacology2011，，2： | 1 |
| 5 | Matrix metalloproteinases, inflammation and atherosclerosis : therapeutic perspectives 显示文摘 | Beaudeux J L Giral P Bruckert E | 2004 | Clin Chem Lab Med2004，42，2： | 1 |
| 6 | Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia显示文摘 | GAGNE C GAUDET D BRUCKERT E | 2002 | Circulation2002，105，21： | 1 |
| 7 | Matrix metalloproteinases, inflammation and atherosclerosis : therapeutic perspectives 显示文摘 | BEAUDEUX J L GIRAL P BRUCKERT E | 2004 | Clin Chern Lab Med2004，42，： | 1 |
| 8 | Matrix metalloproteinases,inflammation and atherosclerosis:therapeutic perspectives显示文摘 | Beaudeux J L Giral P Bruckert E | 2004 | Clin Chem Lab Med2004，42，2： | 1 |
| 9 | Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patient显示文摘 | Kiorsis DN Giral P Bruckert E | | 0，，25： | 1 |
| 10 | Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial显示文摘 | MORIARTY PM JACOBSON TA BRUCKERT E | 2014 | J ClinLipidol2014，8，6： | 1 |
| 11 | Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia显示文摘 | Gagne C Gaudet D Bruckert E | 2002 | Circulation2002，105，21： | 1 |
| 12 | Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial显示文摘 | Vlad Ratziu Philippe Giral Sophie Jacqueminet Fréderic Charlotte Agnès Hartemann–Heurtier Lawrence Serfaty Philippe Podevin Jean–Marc Lacorte Carole Bernhardt Eric Bruckert André Grimaldi Thierry Poynard | 2008 | Gastroenterology2008，，1： | 1 |
| 13 | Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects显示文摘 | Blackbum R Giral P Bruckert E | | 0，，12： | 1 |
| 14 | Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study 显示文摘 | Bruckert E Hayem G Dejager S | 2005 | Cardiovasc Drugs Ther2005，19，6： | 1 |
| 15 | Lowering LDL cholesterol through diet:potential role in the statin era显示文摘 | Bruckert E Rosenbaum D | | 0，，： | 1 |
| 16 | Cysteine Is a Cardiovascular Risk Factor in Hyperlipidemic Patients 显示文摘 | JACOB N BRUCKERT E GIRAL P | 1999 | Atherosclerosis1999，146，： | 1 |
| 17 | Relation between plasminogen activator inhibitor-1 and hepatic enzyme concentrations in hyperlipidemic patients 显示文摘 | Bruckert E Ankri A Giral P | 1994 | Thromb Haemost1994，72，3： | 1 |
| 18 | The abundance of natural nitrogen-15 in the organic matter of soils along an altitudinal gradient 显示文摘 | Mariotti A Piarre D Vedy J C Bruckert S Guillemot J | 1980 | Catena1980，7，： | 1 |
| 19 | Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss显示文摘 | Bastard JP Jardel C Bruckert E | 2000 | Clin Endocrinol Metab2000，85，9： | 1 |
| 20 | Matrix metalloproteinases, inflammation and atherosclerosis :therapeutic perspectives显示文摘 | Beandeux JL Giral P Bruckert E | 2004 | Clin Chem Lab Med2004，42，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员